Nonpeptide Endothelin Receptor Antagonists. XI. Pharmacological Characterization of SB 234551, a High-Affinity and Selective Nonpeptide ETA Receptor Antagonist
- 4 January 2025
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 286 (2) , 650-656
- https://doi.org/10.1016/s0022-3565(24)37635-9
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- SB 234551, a Novel Endothelin-A Receptor Antagonist, Unmasks Endothelin-Induced Renal Vasodilatation in the DogJournal of Cardiovascular Pharmacology, 1998
- Identification and Function of Putative ETB Receptor Subtypes in the Dog KidneyJournal of Cardiovascular Pharmacology, 1995
- EndothelinB Receptor-Mediated Contraction of Human and Rat Pulmonary Resistance Arteries and the Effect of Pulmonary Hypertension on Endothelin Responses in the RatJournal of Cardiovascular Pharmacology, 1995
- Novel Antagonist of Endothelin ETB1 and ETB2 Receptors, BQ-788: Effects on Blood Vessel and Small IntestineBiochemical and Biophysical Research Communications, 1994
- SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.Proceedings of the National Academy of Sciences, 1994
- Characterisation of the endothelin receptor mediating contraction of human pulmonary artery using BQ123 and Ro 46-2005European Journal of Pharmacology, 1994
- Endothelin ETA- and ETB-Receptor-Mediated Vasoconstriction in Rat Pulmonary Arteries and ArteriolesJournal of Cardiovascular Pharmacology, 1994
- A novel subtype of endothelin B receptor mediating contraction in swine pulmonary veinLife Sciences, 1993
- Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRFBritish Journal of Pharmacology, 1993
- Comparative Studies with the Endothelin Receptor Antagonists BQ-123 and PD 142893 Indicate At Least Three Endothelin ReceptorsJournal of Cardiovascular Pharmacology, 1993